Page last updated: 2024-09-03

y 27632 and Retinal Diseases

y 27632 has been researched along with Retinal Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hirata, A; Honjo, M; Inatani, M; Inomata, Y; Kawaji, T; Tanihara, H; Yonemura, N	1

Other Studies

1 other study(ies) available for y 27632 and Retinal Diseases

Article	Year
Y-27632, a Rho-associated protein kinase inhibitor, attenuates neuronal cell death after transient retinal ischemia. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2008, Volume: 246, Issue:1 Topics: Amides; Animals; Cell Death; Cell Survival; Endothelium, Vascular; Enzyme Inhibitors; Immunoenzyme Techniques; In Situ Nick-End Labeling; Leukocytes; Male; Neuroprotective Agents; Pyridines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Retinal Diseases; Retinal Ganglion Cells; Retinal Vessels; rho-Associated Kinases; Silver Staining	2008

Article

Year

Y-27632, a Rho-associated protein kinase inhibitor, attenuates neuronal cell death after transient retinal ischemia.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2008, Volume: 246, Issue:1

Topics: Amides; Animals; Cell Death; Cell Survival; Endothelium, Vascular; Enzyme Inhibitors; Immunoenzyme Techniques; In Situ Nick-End Labeling; Leukocytes; Male; Neuroprotective Agents; Pyridines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Retinal Diseases; Retinal Ganglion Cells; Retinal Vessels; rho-Associated Kinases; Silver Staining

2008